Evidence map›Paper›PMID 39511674›Full record

ArticleGut pathogens2024

Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn's disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis.

Aditya Bajaj, Manasvini Markandey, Amit Samal, Sourav Goswami, Sudheer K Vuyyuru, Srikant Mohta, Bhaskar Kante, Peeyush Kumar, Govind Makharia, Saurabh Kedia and 2 more

Abstract read
In one paragraph

Article in Gut pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Gut microbiota in treatment-naïve active Crohn's disease compared to those in remission: Divergent trends in mucosal versus fecal bacterial community.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aditya Bajaj *Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Manasvini Markandey *Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Amit SamalDepartment of Computational Biology, Indraprastha Institute of Information Technology-Delhi, New Delhi, India.
Sourav GoswamiDepartment of Computational Biology, Indraprastha Institute of Information Technology-Delhi, New Delhi, India.
Sudheer K VuyyuruDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Srikant MohtaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Bhaskar KanteDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Peeyush KumarDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Govind MakhariaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Saurabh KediaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India.
Tarini Shankar GhoshDepartment of Computational Biology, Indraprastha Institute of Information Technology-Delhi, New Delhi, India. tarini.ghosh@iiitd.ac.in.
Vineet AhujaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110029, India. vineet.aiims@gmail.com.

Funding

Indian Council of Medical Research 55/4/11/CARE-ID/2018-NCD-II
6 · The paper itself

Abstract

BACKGROUND/

aimsCrohn's disease (CD) and intestinal tuberculosis (ITB) are gastrointestinal (GI) inflammatory disorders with overlapping clinical presentations but diverging etiologies. The study aims to decipher CD and ITB-associated gut dysbiosis signatures and identify disease-associated co-occurring modules to evaluate whether this dysbiosis signature is a disease-specific trait or is a shared feature across diseases of diverging etiologies.

methodsDisease-associated gut microbial modules were identified using statistical machine learning and co-abundance network analysis in controls, CD and ITB patients recruited as part of this study. Module reproducibility was reinvestigated through meta-network analysis encompassing >5400 bacteriomes and ~900 mycobiomes. Subsequently, >1600 Indian gut microbiomes were analyzed to identify a central-core gut microbiome of 46 taxa, whose abundances aided in the formulation of an India-specific Core Gut Microbiome Score (CGMS) to measure the degree of core retention.

resultsBoth diseases witness similar patterns of alterations in [alpha]-diversity, characterized by a significant reduction in gut bacterial (i.e., bacterial/archaeal) diversity and a concomitant increase in the fungal [alpha]-diversity. Specific bacterial taxa, along with the diverging mycobiome enabled distinction between the diseases. Co-abundance network analysis of these taxa, validated by integrated meta-network analysis, revealed a 'disease-depleted' module, consistent across multiple cohorts, with >75% of this module constituting the central-core Indian gut microbiome. CGMS robustly assessed the core-microbiome loss across different stages of gut inflammatory disorders, in Indian and international cohorts.

conclusionsWhile the disease-specific gain of detrimental bacteria forms an important component of gut dysbiosis, loss of the core microbiome is a shared phenomenon contributing to various GI disorders.

Indexed as

Core gut microbiomeCrohn’s diseaseDysbiosisGut inflammatory disordersGut microbiomeIntestinal tuberculosisMachine learningMicrobiome meta-network analysisMycobiome

Identifiers

PMID39511674
PMCPMC11545864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.